Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q2 2022 Results - Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:NASDAQ:SGMO) Q2 2022 Earnings Conference Call August 04, 2022 04:30 PM ET Company Participants Louise Wilkie - Investor Relations Sandy Macrae - Chief...